Agreement aims to expedite local biomarker testing of NSCLC patients eligible for entrectinib in Japan

Agreement centers on identifying HER2 gene mutations using Oncomine Dx Target Test

Reliable, easy-to-use cryo-EM workflow solution quadruples throughput for pharma labs

Designation follows recent announcement on development of first companion diagnostic using the Oncomine Precision Assay on the new Ion Torrent Genexus System

Agreement calls for identifying IDH gene mutations using Oncomine Precision Assay and the Ion Torrent Genexus System, a new turnkey, next-generation sequencing solution

Expansions enable customers to bring transformative medicines to market faster

New software can be used by pharma, biotech labs to comply with Title 21 CFR Part 11 data integrity regulations